GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhu Healthcare Holding Co Ltd (SHSE:600568) » Definitions » Research & Development

Zhongzhu Healthcare Holding Co (SHSE:600568) Research & Development : ¥12.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Zhongzhu Healthcare Holding Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Zhongzhu Healthcare Holding Co's Research & Development for the three months ended in Mar. 2025 was ¥2.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ¥12.0 Mil.


Zhongzhu Healthcare Holding Co Research & Development Historical Data

The historical data trend for Zhongzhu Healthcare Holding Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongzhu Healthcare Holding Co Research & Development Chart

Zhongzhu Healthcare Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.44 24.68 18.21 16.18 11.96

Zhongzhu Healthcare Holding Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.45 3.58 2.37 3.56 2.52

Zhongzhu Healthcare Holding Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥12.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhongzhu Healthcare Holding Co  (SHSE:600568) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Zhongzhu Healthcare Holding Co Research & Development Related Terms

Thank you for viewing the detailed overview of Zhongzhu Healthcare Holding Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhongzhu Healthcare Holding Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Qinglu South Road, 8th Floor, Building 5, Yanlord Marina Center, Zhuhai, CHN, 519020
Zhongzhu Healthcare Holding Co Ltd produces and sells ophthalmic, antiviral, and anti-infective drugs in China. Its products include eye and nasal drops, injections, solid preparations, and other products. The product consists of Pearl Eye Drops, Sodium Cromolyn Eye Drops, Acyclovir Eye Drops, Hydroxybenzazole Hydrochloride Eye Drops, Acyclovir Dispersible Tablets, Gatifloxacin Tablets.
Executives
Ye Ji Ge Director
Yan Jian senior management
Xu De Lai Director
Li Yong Jun Director
Hu Hua Xia Director
He Xiao Yan senior management
Xiao Li Ling Supervisors
Huang Xiang Ping Director

Zhongzhu Healthcare Holding Co Headlines

No Headlines